HealthEquity, Inc.: chief commercial officer terminated

What happened HealthEquity, Inc. reported that the employment of Michael Fiore, the chief commercial officer, was terminated by the company without cause, effective Oct 5, 2026. The filing says the responsibilities of the chief commercial officer will be redistributed to other members of the company’s management team and that Mr. Fiore will receive previously negotiated severance payments and benefits in consideration of certain actions described in his employment agreement.

Key details

• Termination effective Oct 5, 2026.
• Severance payments and benefits are the previously negotiated amounts set forth in his employment agreement, as detailed in the company’s proxy statement filed May 13, 2026.
• Severance is conditioned on Mr. Fiore’s execution, delivery, and non-revocation of a release of claims and his continuing compliance with certain restrictive covenants.
• Outstanding equity awards will be treated consistent with the terms of the 2014 Stock Incentive Plan, the 2024 Stock Incentive Plan, and his applicable award agreements.

Why it may matter This filing reports Item 5.02: departure of directors or certain officers; that item covers officer departures and related compensatory arrangements, including severance and equity treatment. The filing does not show why the insider traded or why the company acted.